These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1149944)

  • 1. Antifibrin action of phenformin.
    Banerjee RN; Kumar V; Rao SR; Sahni AL; Arya M; Bardhan J
    Diabetologia; 1975 Apr; 11(2):105-11. PubMed ID: 1149944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of phenphormin on blood fibrinolysis in diabetes mellitus.
    Fiaschi E; Barbui T; Previato G; Di Luzio V; Guarnieri GF; Todesco S
    Arzneimittelforschung; 1969 Apr; 19(4):638-40. PubMed ID: 5819165
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative effects of phenformin, metformin and glibenclamide on metabolic rhythms in maturity-onset diabetics.
    Nattrass M; Todd PG; Hinks L; Lloyd B; Alberti KG
    Diabetologia; 1977 Apr; 13(2):145-52. PubMed ID: 404205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of phenformin hydrochloride on serum cholesterol and triglyceride levels of the stable adult diabetic.
    Schwartz MJ; Mirsky S; Schaefer LE
    Metabolism; 1966 Sep; 15(9):808-22. PubMed ID: 5929037
    [No Abstract]   [Full Text] [Related]  

  • 5. Fibrinolytic response of diabetics and non-diabetics to adrenaline.
    Tanser AR
    J Clin Pathol; 1967 May; 20(3):231-3. PubMed ID: 5602554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological stimulation of fibrinolytic activity in the surgical patient.
    Brown IK; Haggart B; Murray GH; Downie RJ; Littler J; Robb PM; Santer GJ
    Lancet; 1971 Apr; 1(7703):774-6. PubMed ID: 4101274
    [No Abstract]   [Full Text] [Related]  

  • 7. Phenformin effect on body weight, lipids, and glucose regulation.
    Alterman SL; Lopez-Gomez AA
    Ann N Y Acad Sci; 1968 Mar; 148(3):884-91. PubMed ID: 4872312
    [No Abstract]   [Full Text] [Related]  

  • 8. Fibrinolytic activity in patients with diabetes mellitus: characterization of the effects of thrombolytic agents on plasma clot lysis in vitro.
    Fears R; Standring R; Abraham R
    Semin Thromb Hemost; 1991 Oct; 17(4):407-11. PubMed ID: 1803510
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical and laboratory double-blind investigation on effect of fibrinolytic therapy in patients with cutaneous vasculitis.
    Dodman B; Cunliffe WJ; Roberts BE; Sibbald R
    Br Med J; 1973 Apr; 2(5858):82-4. PubMed ID: 4573315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of phenformin and metformin in the treatment of maturity onset diabetes.
    Cairns SA; Shalet S; Marshall AJ; Hartog M
    Diabete Metab; 1977 Sep; 3(3):183-8. PubMed ID: 913750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinolytic and defibrinating effect of phenformin plus ethyloestrenol in vivo.
    Fearnley GR; Chakrabarti R; Evans JF
    Lancet; 1969 May; 1(7601):910-4. PubMed ID: 4180895
    [No Abstract]   [Full Text] [Related]  

  • 12. Idiopathic recurrent superficial thrombophlebitis: treatment with fibrinolytic enhancement.
    Jarrett PE; Morland M; Browse NL
    Br Med J; 1977 Apr; 1(6066):933-4. PubMed ID: 856391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of phenformin on serum cholesterol and triglyceride levels in diabetes mellitus.
    Singh VS; Mehrotra TN; Aggarwal K; Sharma A; Nath K
    Indian J Med Sci; 1978; 32(5-6):43-8. PubMed ID: 753757
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypoglycemic treatments and the fibrinolytic system in maturity-onset diabetes mellitus without thromboembolic manifestations.
    Gamba G; Grignani G; Biancardi M; De Marco R; Grassi M; Ferrari E
    Acta Diabetol Lat; 1983; 20(1):63-70. PubMed ID: 6858544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinolysis and its pharmacological enhancement in occlusive vascular disease.
    Fearnley GR
    Adv Cardiol; 1970; 4():211-24. PubMed ID: 4924083
    [No Abstract]   [Full Text] [Related]  

  • 16. [Initial results in the treatment of diabetes mellitus with an association of glibenclamide and phenformin].
    Carta Q; Pugliese F
    Minerva Med; 1974 Jan; 65(1):27-57. PubMed ID: 4214410
    [No Abstract]   [Full Text] [Related]  

  • 17. Fibrinolytic effect of biguanides.
    Fearnley GR; Chakrabarti R; Hocking ED; Evans J
    Ann N Y Acad Sci; 1968 Mar; 148(3):840-7. PubMed ID: 5241480
    [No Abstract]   [Full Text] [Related]  

  • 18. Fibrinolytic effects of defibrotide in atherosclerotic patients.
    Patrassi GM; Sartori MT; Viero ML; Scapinello MP; Boeri G; Girolami A
    Semin Thromb Hemost; 1991; 17 Suppl 1():101-5. PubMed ID: 2068562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Physiological and pharmacological aspects of fibrinolysis].
    Fearnley GR
    Clin Ter; 1971 May; 57(3):205-25. PubMed ID: 5110942
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological fibrinolysis in diabetes mellitus.
    Chakrabarti R; Fearnley GR
    Diabetologia; 1974 Feb; 10(1):19-22. PubMed ID: 4835611
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.